Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data
Divya Ramamoorthy,Kristen Severson,Soumya Ghosh,Karen Sachs,Answer ALS,Jonathan D Glass,Christina N Fournier,Pooled Resource Open-Access ALS Clinical Trials Consortium,ALS/MND Natural History Consortium,Todd M Herrington,James D Berry,Kenney Ng,Ernest Fraenkel,Emily G Baxi,Alyssa N Coyne,Elizabeth Mosmiller,Lindsey Hayes,Aianna Cerezo,Omar Ahmad,Promit Roy,Steven Zeiler,John W Krakauer,Jonathan Li,Aneesh Donde,Nhan Huynh,Miriam Adam,Brook T Wassie,Alex Lenail,Natasha Leanna Patel-Murray,Yogindra Raghav,Velina Kozareva,Stanislav Tsitkov,Tobias Ehrenberger,Julia A Kaye,Leandro Lima,Stacia Wyman,Edward Vertudes,Naufa Amirani,Krishna Raja,Reuben Thomas,Ryan G Lim,Ricardo Miramontes,Jie Wu,Vineet Vaibhav,Andrea Matlock,Vidya Venkatraman,Ronald Holewenski,Niveda Sundararaman,Rakhi Pandey,Danica-Mae Manalo,Aaron Frank,Loren Ornelas,Lindsey Panther,Emilda Gomez,Erick Galvez,Daniel Perez,Imara Meepe,Susan Lei,Louis Pinedo,Chunyan Liu,Ruby Moran,Dhruv Sareen,Barry Landin,Carla Agurto,Guillermo Cecchi,Raquel Norel,Sara Thrower,Sarah Luppino,Alanna Farrar,Lindsay Pothier,Hong Yu,Ervin Sinani,Prasha Vigneswaran,Alexander V Sherman,S Michelle Farr,Berhan Mandefro,Hannah Trost,Maria G Banuelos,Veronica Garcia,Michael Workman,Richie Ho,Robert Baloh,Jennifer Roggenbuck,Matthew B Harms,Carolyn Prina,Sarah Heintzman,Stephen Kolb,Jennifer Stocksdale,Keona Wang,Todd Morgan,Daragh Heitzman,Arish Jamil,Jennifer Jockel-Balsarotti,Elizabeth Karanja,Jesse Markway,Molly McCallum,Tim Miller,Ben Joslin,Deniz Alibazoglu,Senda Ajroud-Driss,Jay C Beavers,Mary Bellard,Elizabeth Bruce,Nicholas Maragakis,Merit E Cudkowicz,James Berry,Terri Thompson,Steven Finkbeiner,Leslie M Thompson,Jennifer E Van Eyk,Clive N Svendsen,Jeffrey D Rothstein,Alexander Sherman,Christian Lunetta,David Walk,Ghazala Hayat,James Wymer,Kelly Gwathmey,Nicholas Olney,Terry Heiman-Patterson,Ximena Arcila-Londono,Kenneth Faulconer,Ervin Sanani,Alex Berger,Julia Mirochnick
DOI: https://doi.org/10.1038/s43588-022-00299-w
Abstract:The clinical presentation of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease, varies widely across patients, making it challenging to determine if potential therapeutics slow progression. We sought to determine whether there were common patterns of disease progression that could aid in the design and analysis of clinical trials. We developed an approach based on a mixture of Gaussian processes to identify clusters of patients sharing similar disease progression patterns, modeling their average trajectories and the variability in each cluster. We show that ALS progression is frequently nonlinear, with periods of stable disease preceded or followed by rapid decline. We also show that our approach can be extended to Alzheimer's and Parkinson's diseases. Our results advance the characterization of disease progression of ALS and provide a flexible modeling approach that can be applied to other progressive diseases.